Memo M - Search Results

1

Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line.

Uberti D, Rizzini C, Spano PF, Memo M. Uberti D, et al. Among authors: memo m. Neurosci Lett. 1997 Oct 17;235(3):149-53. doi: 10.1016/s0304-3940(97)00715-5. Neurosci Lett. 1997. PMID: 9406891

2

Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas.

Govoni S, Memo M, Spano PF, Trabucchi M. Govoni S, et al. Among authors: memo m. Toxicology. 1979 Mar-Apr;12(3):343-9. doi: 10.1016/0300-483x(79)90081-7. Toxicology. 1979. PMID: 494315

3

Rat pituitary cells selectively express mRNA encoding the short isoform of the y2 GABAA receptor subunit.

Valerio A, Tinti C, Spano P, Memo M. Valerio A, et al. Among authors: memo m. Brain Res Mol Brain Res. 1992 Mar;13(1-2):145-50. doi: 10.1016/0169-328x(92)90054-f. Brain Res Mol Brain Res. 1992. PMID: 1315911

4

Selective expression of the mRNA encoding the short isoform of the gamma 2 GABA-A receptor subunit in rat pituitary cells.

Valerio A, Spano PF, Memo M. Valerio A, et al. Among authors: memo m. Adv Biochem Psychopharmacol. 1992;47:81-5. Adv Biochem Psychopharmacol. 1992. PMID: 1324590 Review. No abstract available.

5

The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs.

Memo M, Missale C, Pizzi M, Spano PF. Memo M, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:458A-459A. doi: 10.1097/00002826-199201001-00239. Clin Neuropharmacol. 1992. PMID: 1354049 No abstract available.

6

Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats.

Nisoli E, Tonello C, Memo M, Pizzi M, Spano P, Reina G, Carruba MO. Nisoli E, et al. Among authors: memo m. Eur J Pharmacol. 1992 May 27;216(1):81-6. doi: 10.1016/0014-2999(92)90212-m. Eur J Pharmacol. 1992. PMID: 1356088

7

Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells.

Memo M, Pizzi M, Belloni M, Benarese M, Spano P. Memo M, et al. J Neurochem. 1992 Nov;59(5):1829-35. doi: 10.1111/j.1471-4159.1992.tb11016.x. J Neurochem. 1992. PMID: 1357100

8

Pharmacological basis for dopamine D-2 receptor diversity.

Memo M, Pizzi M, Valerio A, Missale C, Carruba MO, Spano PF. Memo M, et al. Neurochem Int. 1992 Mar;20 Suppl:185S-187S. doi: 10.1016/0197-0186(92)90236-k. Neurochem Int. 1992. PMID: 1365423 Review. No abstract available.

9

Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats.

Valerio A, Tinti C, Ribola M, Pizzi M, Memo M, Spano PF. Valerio A, et al. Among authors: memo m. Pharmacol Res. 1992 Feb-Mar;25 Suppl 1:107-8. doi: 10.1016/1043-6618(92)90562-p. Pharmacol Res. 1992. PMID: 1508787 No abstract available.

10

Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man.

Pizzi M, Rubessa S, Simonazzi E, Zanagnolo V, Falsetti L, Memo M, Spano PF. Pizzi M, et al. Among authors: memo m. J Endocrinol. 1992 Feb;132(2):311-6. doi: 10.1677/joe.0.1320311. J Endocrinol. 1992. PMID: 1541929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters